Cannabinoids: for better and for worse

Thibaut, Florence; Hoehe, Margret R.

doi:10.31887/DCNS.2020.22.3/fthibaut

Datensatz

DATENSATZ AKTIONENEXPORT

Zur Ablage hinzufügen

Lokale TagsFreigabegeschichteDetailsÜbersicht

Freigegeben

Zeitschriftenartikel

Cannabinoids: for better and for worse

MPG-Autoren

/persons/resource/persons50204

Hoehe, Margret R.
Diploid Genomics (Margret R. Hoehe), Dept. of Computational Molecular Biology (Head: Martin Vingron), Max Planck Institute for Molecular Genetics, Max Planck Society;

Externe Ressourcen

Es sind keine externen Ressourcen hinterlegt

Volltexte (beschränkter Zugriff)

Für Ihren IP-Bereich sind aktuell keine Volltexte freigegeben.

Volltexte (frei zugänglich)

Thibaut_2020.pdf
(Verlagsversion), 235KB

Ergänzendes Material (frei zugänglich)

Es sind keine frei zugänglichen Ergänzenden Materialien verfügbar

Zitation

Thibaut, F., & Hoehe, M. R. (2020). Cannabinoids: for better and for worse. Dialogues in Clinical Neuroscience, 22(3), 201-204. doi:10.31887/DCNS.2020.22.3/fthibaut.

Zitierlink: https://hdl.handle.net/21.11116/0000-0007-60DD-4

Zusammenfassung

The use of cannabis as a drug has undergone a remarkable change of direction: considered as a symbol of countercultures in past decades, it is presently being hailed as a cure for any number of diseases and conditions. Thus, despite concerns about the safety of cannabis and cannabinoids, quite a few drugs that contain cannabinoids have recently been approved by several drug agencies, and the medicinal and recreational use of cannabis has been legalized in various countries and states. The promise of cannabinoids for therapeutic use, as well as potentially detrimental health risks and regulatory issues, will need to be carefully weighed. 